BRTX — Biorestorative Therapies Share News
0.000.00%
Last trade - 00:00- $2.24m
- -$1.35m
- $0.36m
BioRestorative Therapies Inc reports results for the quarter ended in June - Earnings Summary
BioRestorative Therapies Inc expected to post a loss of $1.19 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-NuZee, AAON, Gold miners
BioRestorative rises on recommendation to proceed mid-stage study of lead therapy
Brief: BioRestorative Therapies Got Unanimous Recommendation To Proceed Phase 2 Trial For Chronic Lumbar Disc Disease, BRTX-100
U.S. RESEARCH ROUNDUP-Eli Lilly, Regeneron Pharmaceuticals, Synopsys
Brief: Biorestorative Therapies Receives Unanimous Recommendation From Data Safety Monitoring Board To Continue Phase 2 Clinical Trial Without Any Changes
BioRestorative up on completing patient dosing in spine disease drug trial
Brief: Biorestorative Therapies Receives License From New York State Department Of Health To Act As Tissue Bank For Mesenchymal Stem Cell Processing
Brief: Biorestorative Therapies Receives Allowance By The Japanese Patent And Trademark Office
U.S. STOCKS ON THE MOVE-Tyson Foods, Estee Lauder, Energy stocks
Brief: Biorestorative Therapies And Northwell Health Enter Into Agreement To Participate In The Company’S Phase 2 Clinical Trial
BioRestorative rises on agreement with Northwell Health
Brief: BioRestorative Therapies Announces Completion Of Patient Enrollment For Safety Run-In Component Of Its Phase 2 Clinical Study Of BRTX-100
U.S. STOCKS ON THE MOVE-Moderna, Genie Energy, Merck & Co
U.S. STOCKS ON THE MOVE-Tesla, Rivian, Phathom Pharmaceuticals
U.S. STOCKS ON THE MOVE-Eli Lilly, Mersana, Illumina
BioRestorative up on partnership to help expand lead therapy clinical application
Brief: Biorestorative Therapies To Seek FDA Approval To Expand The Clinical Application Of BRTX-100